Farther Finance Advisors’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28K Buy
2,147
+1,010
+89% +$11.5K ﹤0.01% 3716
2026
Q1
$13.6K Sell
1,137
-881
-44% -$9.55K ﹤0.01% 3920
2025
Q4
$25.9K Buy
2,018
+1,199
+146% +$14.8K ﹤0.01% 3263
2025
Q3
$9.15K Buy
819
+699
+583% +$6.75K ﹤0.01% 3480
2025
Q2
$1.19K Sell
120
-20
-14% -$196 ﹤0.01% 3861
2025
Q1
$1.35K Hold
140
﹤0.01% 3524
2024
Q4
$1.28K Hold
140
﹤0.01% 3168
2024
Q3
$1.09K Buy
140
+20
+17% +$144 ﹤0.01% 3218
2024
Q2
$686 Hold
120
﹤0.01% 3195
2024
Q1
$700 Sell
120
-354
-75% -$2.1K ﹤0.01% 2911
2023
Q4
$3.72K Buy
+474
New +$3.29K ﹤0.01% 2115
2023
Q2
Sell
-16
Closed -$165 2499
2023
Q1
$165 Hold
16
﹤0.01% 2226
2022
Q4
$220 Buy
+16
New +$223 ﹤0.01% 2023

Other funds holding ANGO

Farther Finance Advisors's ANGO Position: Q2 2026 in Review

Farther Finance Advisors increased its AngioDynamics (ANGO) stake by 89% in Q2 2026, buying an estimated $11.5K and bringing the position to 2,147 shares worth $28K. The position accounts for ﹤0.01% of the portfolio, ranked #3716.

Farther Finance Advisors first reported a position in ANGO in Q4 2022 and has held it in 13 quarters since. 16 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Farther Finance Advisors held 2,147 shares of AngioDynamics worth $28K as of Q2 2026.
  • Farther Finance Advisors bought 1,010 AngioDynamics shares in Q2 2026, an estimated $11.5K.
  • AngioDynamics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #3716 holding.
  • Farther Finance Advisors first reported a position in AngioDynamics in Q4 2022 and has held it in 13 quarters since.
  • 16 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.